Skip to content

MyOnyx SA9000

by Thought Technology Ltd.

MyOnyx SA9000 is a Class II device made by Thought Technology Ltd., cleared under FDA 510(k) K053434 on 15 Mar 2006 and listed in FDA GUDID since 16 Jul 2020 (UDI-DI 07540191000555), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K053434

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number07540191000555 UDI-DI Date16 Jul 2020ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK053434 Date15 Mar 2006DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K053434 decided 15 Mar 2006 Active
  • FDA GUDID UDI-DI 07540191000555 listed 16 Jul 2020 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K053434
  2. Listed FDA GUDID 07540191000555

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
MyOnyx
Generic name
Psychophysiological biofeedback system
Model / reference
SA9000
Primary DI / UDI-DI
07540191000555
510(k) Number
FDA product code
HCC, KPI, IPF
GMDN term
Psychophysiological biofeedback system
Device class
Class II
Regulation number
882.5050, 876.5320, 890.5850
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code HCC (Device, Biofeedback).

Other devices from Thought Technology Ltd.

See all devices from Thought Technology Ltd. →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)